Skip to main content

Table 3 Index therapy change within 6 months and full study period

From: A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy

 

Within 6 months

Across full study period

 

Latanoprost

N = 632

Travoprost-Z

N = 268

Latanoprost

N = 632

Travoprost-Z

N = 268

Changed therapy, n %

134 (21.2)

77 (28.7)

218 (34.5)

121 (45.2)

   p-value*

0.0148

0.0026

Hazard ratio†

1.519

1.499

   p-value

0.0035

0.0004

Days to change

    

   Mean ± SD

72.9 ± 51.2

54.1 ± 48.0

194.8 ± 192.9

178.0 ± 196.7

   Median

56.5

40.0

125.0

90.0

  1. SD = standard deviation.
  2. *Chi-square test.
  3. †The reference cohort is latanoprost. Based on the Cox proportional hazards model.